Alan Ekanem
Mobile Phone: 954-***-****
Secondary Phone: 954-***-****
Alternate E-mail: abm715@r.postjobfree.com
Alan Ekanem, M.D., B.Sc
CLiNICAL RESEARCH
Alan Ekanem, M.D., B.Sc
Contact Address: 11902 SW 13th Court
Davie, FL, 33325.
Telephone: 954-***-****
Email: abm715@r.postjobfree.com
education
M.D. Medicine & Surgery 1998
University of Jos, Plateau State, Nigeria.
B.Sc. (Physiology) 1988
University of Calabar, Cross river State, Nigeria
THERAPEuTIC EXPERIENCE
Circulatory: Venous Thromboembolism
Digestive System: Gastroenterology
Musculoskeletal: Orthopedics: Osteoporosis
Professional experience
PPD, Morrisville, NC Sr. CRA August 2007-present
CRA: Perform and coordinate assigned aspects of the clinical monitoring
process in accordance with GCPs and global SOPs to assess the safety and
efficacy of investigational products and/or medical devices. Conduct site
visits to determine protocol and regulatory compliance, and prepares
required documentation. Develop collaborative relationships with
investigative sites and client company personnel.
Registrar Department of Internal Medicine., University of Jos Teaching
Hospital, Plateau State,Jos, Nigeria
Registrar Feb 2007-Jun 2007
. Tertiary Practice of medicine, attending to patients referred from
primary and secondary medical institutions for Internal medicine
related cases.
. Lecturing House Officers and Medical students in dept of medicine.
National Institute for Pharmaceutical Research and Development Nigeria
Project Coordinator Jan 2004-Nov 2006
. Coordinated multicenter Clinical Trials at different Phases.
. Performed clinical monitoring in compliance with National Drug
regulations and all related protocols and regulations.
. Monitoring visits include evaluation, initiation, interim and close
out visits.
. Instructed the investigational site staff in their roles and
responsibilities in conducting clinical studies and evaluates
performance and compliance in conducting clinical studies.
. Coordinated collection of information from investigational site.
. Participated in investigator meetings.
. Completed trip reports and responsible for all communication with
sites.
National Medical Center, Abuja, Nigeria
Project Coordinator/Out patient Physician Apr
2001-Nov 2003
. Conducted site evaluation visits and supervised potential and approved
study sites with the ongoing Clinical trial of an investigational drug
for the study subjects enrolled in a phase II multi-center trials for
prophylactic antituberculous (Isoniazid) drug study for patients with
positive PPD test, a phase I/II multi- center trials for anthelminthic
drug (praziquantel) on study subject and a phase II multi-center
clinical trial for antimalarial drug (proguanil).
. Conducted site evaluation visits, ensured compliance with study
protocol, prepared site visit reports and informed consents.
. Conducted site-evaluation visits to perform facility assessments and
investigators profile review.
. Tracked and assisted in the review of pre-study documents to ensure
completeness and accuracy.
. Ensured clinical supplies were properly stored, dispensed and
accounted for.
. Conducted pre-study visits, with project manager/ project MD reviewing
study data and resolving data queries, assisted with protocol and CRF
development.
. Reviewed clinically related progress reports.
. Participated in investigator and other training meetings.
. Participated in the collection and review of
safety/scientific/technical information.
St. Joseph Medical Center (Nigeria) in Conjunction with World Health
Organization. (WHO assisted program)
Project Coordinator/Physician Oct 2000-Mar 2001
. Conducted clinical studies and surveys on the effectiveness of
antiviral drugs used in HIV/AIDS.
. Routine hospital site assessment visits and review of Data collection
on viral loads, symptoms progression, adverse experiences and patient
interviews.
. Conducted/supervised pharmacy inventory and drug accountability
procedures.
. Supervised and trained a team of 30 study nurses and community health
assistants on study conduct procedures and methods of clinical study
documentation.
. Conducted clinical trials and surveys on the extent of P. falciparum
resistance to antimalarial drug, Chloroquine in the holoendemic
malaria regions.
Medical House
Officer (Intern) Aug 1999-Sep
2000
. Practice of Medicine at the General Hospital, Lagos, Lagos State,
Nigeria.
. Management of in-and out-patient under supervision in major fields of
Medicine.
World health Organization grants/Ministry of Health, Nigeria
Research Fellow Sep 1990-Dec 1990
. Evaluated the extent of XXX resistance to XXX medication and to
determine the effectiveness of the
newly introduced WHO impregnated mosquito bed netting.
CCCD/Ministry of Health, Nigeria
Clinical Research Fellow May 1990-Jun 1990
. Clinical evaluation of Chloroquine resistance in Orionhwon, Edo state,
Nigeria.
. Screened for suitable patients and comparing effects of Chloroquine on
P. falciparum parasitaemia,
. Also ensured follow-up of test and control patients/data collation.
Clinical Research Fellow Sep 1989-Oct 1989
. Clinical evaluation of Chloroquine resistance in Ahoda, Rivers state,
Nigeria.
. Screened for suitable patients and comparing effects of Chloroquine on
P. falciparum parasitaemia,
. Also ensured follow-up of test and control patients/data collation.
LIcenses & Certifications
. United States Medical Licensing Examination (USMLE) Completed and
Educational Commission for foreign medical graduates (ECFMG)
certification, Philadelphia. USA, March 29, 2007
. Nigeria Medical Council, Annual practicing License, MDCN/R/ 34266 Aug
2, 2007.
Professional Development
Training while employed at PPD is available upon request.
. Extensive and Comprehensive training in all fields in basic medical
sciences physiology, anatomy,biochemistry, community medicine) and
Clinical
sciences(hematology,oncology,pathology,microbiology,pharmacology,medici
ne, surgery, paediatrics,obstetrics / gynaecology,psychiatry and
radiology in a requirement for M.D. degree.
. Trained to perform clinical ECG recordings, Sep 21, 2001
PROFESSIONaL AFFILIATIONS
. Nigerian Medical and Dental Council, Oct 19, 2000.
. Nigerian Society of physiology, Aug 20 1988.
PUBLICATIOnS ANd PRESENTATIONS
Publications:
An evaluation of the efficacy of three antimalarial drugs in the treatment
of malaria during pregnancy. January 2001.
?n assessment of the expanded program on immunization in major cities in
Nigeria. May 2004.
An evaluation of immunization coverage after 6 years of vaccination
campaign. June 2005
The Haematological and Anthropometric effects of daily fresh milk in
primary school children in akampka. Bsc Thesis 1988.
Presentations:
Panel discussion on the treatment of Enteric fever, Plateau state public
corporation, Jos, Nigeria (2003). To educate people on the symptoms,
prevention /treatment of Enteric fever.
Enlightenment program on the importance of water to the Human System,
Health Group, Lagos state, Nigeria (2003).
Lecture on the effect of Hypertension and hypercholesterolemia on the
society. Health Group, Corporation, Abuja, Nigeria (2002). To educate
Police officers on the effect of Hypertension and its prevention.
Computer Experience
Microsoft Office, PowerPoint, Excel
LANGUAGES
Proficient in English, and Yoruba
Clinical Trial Experience
Circulatory: Phase III multi center Clinical trial of an Investigational
drug for prophylactic and acute treatment of patients with deep vein
thrombosis and pulmonary embolism.
Infections/Parasitic Diseases: Conducted clinical studies and surveys on
the effectiveness of antiviral drugs used in HIV/AIDS.
Infections/Parasitic Diseases: Routine hospital site monitoring visits for
Data collection on viral loads, symptoms progression, adverse experiences
and patient interviews.
Infections/Parasitic Diseases: Conducted clinical trials and surveys on the
extent of XXX resistance to antimalarial drug, XXX in the holoendemic
malaria regions.
Infections/Parasitic Diseases: Clinical trial of an investigational drug
for the study subjects enrolled in a phase II multi-center trials for
prophylactic antituberculous XXX drug study for patients with positive PPD
test, a phase I / II multi-center trials for anthelminthic drug XXX on
study subject and a phase II multi-center clinical trial for antimalarial
drug XXX.